Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
A Z-Pak (azithromycin) usually begins fighting bacteria within hours of the first dose, but most people do not notice symptom relief until 24 to 72 hours in, with steady improvement over the 5-day course. Because azithromycin stays in body tissues for days, it keeps working even after the last pill, which is why some people feel better only near the end or shortly after finishing. Timing varies by infection type, severity, your immune health, and whether the illness is actually bacterial, so there are several important factors to consider below. Fever or symptoms that persist beyond 72 hours, worsen at any point, or return after treatment can signal a resistant organism, a viral cause, or a complication that needs re-evaluation.
If you are unsure whether your symptoms are improving on schedule or heading in the wrong direction, a free, instant, online symptom check can help you compare what you are feeling against likely causes and clarify whether you should wait it out, call your prescriber, or seek urgent care today.
Last reviewed for medical accuracy: 09/24/2026
A Z-Pak, containing the antibiotic azithromycin, is commonly prescribed for respiratory infections, skin infections, ear infections and more. If you’ve just started a Z-Pak, you’re probably wondering when you’ll begin to feel better. Here’s what to expect—and how to support your recovery—based on credible medical sources.
Within 24 Hours
48–72 Hours
By Day 5 (End of Course)
Note: Individual response varies. Factors such as the type of infection, severity, other medications and your overall health can speed up or slow down improvement.
Most people tolerate azithromycin well, but you may experience:
Rare but serious side effects (seek immediate medical help if you notice):
Even with a Z-Pak, some infections require more monitoring:
For non-emergency questions, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. If anything feels serious—especially chest pain, trouble breathing or allergic reactions—seek in-person medical attention immediately.
Q: Can I stop the Z-Pak once I feel better?
A: No. Stopping early can allow bacteria to survive, leading to relapse or resistance. Finish all five days.
Q: Is azithromycin safe with other medications?
A: Generally yes, but check with your pharmacist or doctor about antacids, blood thinners or heart medications.
Q: Can I drink alcohol while on a Z-Pak?
A: Moderate alcohol use isn’t typically a problem, but alcohol can worsen dehydration and upset stomach.
Speak to your healthcare provider if you have any questions or if your condition doesn’t improve as expected.
(References)
* Lockwood AM, Cole S, Rabinovich M. Azithromycin-induced liver injury. Am J Health Syst Pharm. 2010 May 15;67(10):810-4. doi: 10.2146/ajhp080687. PMID: 20479103.
* Hill DR, Beeching NJ. Travelers' diarrhea. Curr Opin Infect Dis. 2010 Oct;23(5):481-7. doi: 10.1097/QCO.0b013e32833dfca5. PMID: 20683261.
* Bakheit AH, Al-Hadiya BM, Abd-Elgalil AA. Azithromycin. Profiles Drug Subst Excip Relat Methodol. 2014;39:1-40. doi: 10.1016/B978-0-12-800173-8.00001-5. PMID: 24794904.
* Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu J, Serrano J, United States Drug Induced Liver Injury Network. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. Gastroenterology. 2015 Jun;148(7):1340-52.e7. doi: 10.1053/j.gastro.2015.03.006. Epub 2015 Mar 6. PMID: 25754159; PMCID: PMC4446235.
* Casas-Maldonado F. Bronchiectasis and Azithromycin. Arch Bronconeumol (Engl Ed). 2018 Feb;54(2):61-62. doi: 10.1016/j.arbres.2017.06.025. Epub 2017 Jul 28. PMID: 28757281.
* Barks JDE, Liu Y, Wang L, Pai MP, Silverstein FS. Repurposing azithromycin for neonatal neuroprotection. Pediatr Res. 2019 Oct;86(4):444-451. doi: 10.1038/s41390-019-0408-6. Epub 2019 May 17. PMID: 31100754; PMCID: PMC6764891.
* Johnson JM, Yost RJ, Pangrazzi MH, Golden KA, Soubani AO, Wahby KA. Azithromycin and Septic Shock Outcomes. J Pharm Pract. 2023 Jun;36(3):559-565. doi: 10.1177/08971900211064193. Epub 2021 Dec 30. PMID: 34967253.
* Langton Hewer SC, Smith S, Rowbotham NJ, Yule A, Smyth AR. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst Rev. 2023 Jun 2;6(6):CD004197. doi: 10.1002/14651858.CD004197.pub6. Epub 2023 Jun 2. PMID: 37268599; PMCID: PMC10237531.
* Iwasaki T, Koide K, Kido T, Nakagawa S, Goto M, Kenri T, Suzuki H, Otsuka N, Takada H. Fatal case of macrolide-resistant Bordetella pertussis infection, Japan, 2024. J Infect Chemother. 2025 Jul;31(7):102727. doi: 10.1016/j.jiac.2025.102727. Epub 2025 May 8. PMID: 40348379.
* Thomas D, Hamada Y, Gibson P, Brightling CE, Castro M, Heaney LG. Diagnosis and Treatment Options for T2-Low Asthma. J Allergy Clin Immunol Pract. 2025 Jul;13(7):1527-1539. doi: 10.1016/j.jaip.2025.04.055. Epub 2025 May 13. PMID: 40373870.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.